NPM1 and acute myeloid leukemia: As per the latest MRD guidelines from the ELN, molecularly defined groups such as NPM1-mutated AML should be monitored by qPCR and ddPCR; the implication of both approaches have been extensively published and reviewed [2,6,60,61,68].